In 2025 ECN very proudly sponsored the following academic research publications:

 

“Risk Factors and Outcome of Asparaginase-associated Pancreatitis in Pediatric Acute Lymphoblastic Leukemia”, by Seham Hassan, Sonia Ahmed, Nesreen Ali, Abeer Mokhles, Iman Zaky, Hala Reda, Sarah H Youssef, Dina Hammad, Omneya Hassanain and Iman Sidhom

 

“A pilot metabolomic study for diagnosing Aspergillus infection in immunocompromised pediatric cancer patients”, by Taghreed Khaled Abdelmoneim, Asmaa Ramzy, Mostafa Ahmed Zaki, Ahmed Karam, Ahmed Hesham, Aya Osama, Nabila Sabar, Maha Mokhtar, Nada A. Youssef, Eman A. Ahmed, Lobna Shalaby, Asmaa Salama, Ahmed Kamel, Mervat Elanany and Sameh Magdeldin

 

“Integrative Mulil-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures”, by Aya Osama, Ahmed Karam, Abdelrahman Atef, Menna Arafat, Rahma W. Afifi, Maha Mokhtar, Taghreed Khaled Abdelmoneim, Asmaa Ramzy, Enas EL Nadl, Asmaa Salama, Emad Elzayat, and Sameh Magdeldln.

 

“Changes in Gut Microbial Diversity and Correlation with Clinical Outcome in Children with Acute Myeloid Leukemia Receiving Induction Chemotherapy”, by Mai Adel, Reham Abdelaziz Khedr, Ahmed A. Sayed, Lobna Shalaby, Aya A. Diab, Abdelrahman Yahia, Mervat Elanany, Leslie E. Lehmann, Sonia Ahmed Ramy K. Aziz, and Alaa Elhaddad

 

ECN is also currently supporting the Car-T Cell Research Program at CCHE:

 

CCHE is developing a platform to deliver Chimeric Antigen Receptor (CAR)-T cell therapy, a type of therapy using the patients own immune system to fight the disease,  for patients with certain kinds of leukemia and lymphoma. The patients’ own T cells will be genetically engineered at CCHE. A team, led by Dr. Alaa ElHaddad and comprised of senior and junior physicians and a pharmacist,  was awarded a grant sponsored by the DFCI Center of Global Health to spend a week in Boston meeting with the DFCI team to develop the necessary policies and procedures. CCHE will be the 1st Egyptian center to offer this important and novel therapy.

 

Conferences supported by ECN in 2024 & 2025

 

In 2025:

JANUARY 7 TO 19, 2025

ECN sponsored the attendance for Dr. Riham Abdel Aziz, Dr. Khaled Hassan, and Dr. Hisham Monieb to the International Meeting of Simulation in Health (IMSH) Conference, taking place in Orlando Florida, as well as visits to Medical Simulation Centers in Florida and New York.

 

In 2024:

June 3-9,2024

ECN Sponsored the attendance for Dr. Mona Mohamed to present her research on Expression of VEFGR, PDGFR, and C-Kit in Pediatric Non-Rhabdomyosarcoma Soft Tissues Sarcoma & Correlation with the Outcome at the SIOP Conference in Johannesburg, South Africa

 

June 12-18,2024

ECN sponsored the attendance of Dr. Nadine Ahmed to present her research on Clinical Implication of RAS mutation in low risk pediatric acute myeloid leukemia patients, as well as Dr. Nessma Shahin to present her research on the impact of delayed hematological recovery on the outcome in acute myeloid leukemia with negative minimal residual disease post induction I in children the EHA Conference, European Hematology Association Meeting in Madrid, Spain

.